Comment on "Review of Case Narratives from Fatal Overdoses Associated with Injectable Naltrexone for Opioid Dependence".
作者信息
Silverman Bernard, Bloomgren Gary, Jain Priya, Marcopul Kimberley, Silveira Alexandra, Fratantonio James, Sullivan Maria, Akerman Sarah
机构信息
Alkermes, Inc, Waltham, MA, USA.
Clinical Psychiatry, Columbia University, New York, NY, USA.
出版信息
Drug Saf. 2018 Oct;41(10):991-993. doi: 10.1007/s40264-018-0691-x.
Abstract
摘要
相似文献
1
Comment on "Review of Case Narratives from Fatal Overdoses Associated with Injectable Naltrexone for Opioid Dependence".关于《与用于阿片类药物依赖的注射用纳曲酮相关的致命过量案例叙述回顾》的评论
Drug Saf. 2018 Oct;41(10):991-993. doi: 10.1007/s40264-018-0691-x.
2
Authors' Response to Silverman and Colleagues' Comment on "Review of Case Narratives from Fatal Overdoses Associated with Injectable Naltrexone for Opioid Dependence".作者对西尔弗曼及其同事就《与用于阿片类药物依赖的注射用纳曲酮相关的致命过量用药病例叙述回顾》所做评论的回应。
Drug Saf. 2018 Oct;41(10):995-997. doi: 10.1007/s40264-018-0692-9.
3
Review of Case Narratives from Fatal Overdoses Associated with Injectable Naltrexone for Opioid Dependence.注射用纳曲酮治疗阿片类药物依赖致致命过量病例报告综述。
Drug Saf. 2018 Oct;41(10):981-988. doi: 10.1007/s40264-018-0653-3.
4
Concerns about injectable naltrexone for opioid dependence.对用于阿片类药物依赖的注射用纳曲酮的担忧。
Lancet. 2011 Apr 30;377(9776):1468-70. doi: 10.1016/S0140-6736(10)62056-9.
5
Injectable extended-release naltrexone for opioid dependence.用于阿片类药物依赖的注射用长效纳曲酮
Lancet. 2011 Aug 20;378(9792):665; author reply 666. doi: 10.1016/S0140-6736(11)61331-7.
6
Injectable extended-release naltrexone for opioid dependence.用于阿片类药物依赖的注射用缓释纳曲酮。
Lancet. 2011 Aug 20;378(9792):665-6; author reply 666. doi: 10.1016/S0140-6736(11)61332-9.
7
Naltrexone: Not Just for Opioids Anymore.纳曲酮：不再仅仅用于阿片类药物。
J Med Toxicol. 2016 Mar;12(1):71-5. doi: 10.1007/s13181-015-0512-x.
8
Injectable extended-release naltrexone for opioid dependence.用于阿片类药物依赖的注射用长效纳曲酮
Lancet. 2011 Aug 20;378(9792):664-5; author reply 666. doi: 10.1016/S0140-6736(11)61330-5.
9
Injectable extended-release naltrexone (XR-NTX) for opioid dependence: long-term safety and effectiveness.注射用延长释放型纳曲酮（XR-NTX）治疗阿片类药物依赖：长期安全性和有效性。
Addiction. 2013 Sep;108(9):1628-37. doi: 10.1111/add.12208. Epub 2013 May 24.
10
Sustained-release naltrexone: novel treatment for opioid dependence.长效纳曲酮：阿片类药物依赖的新型治疗方法。
Expert Opin Investig Drugs. 2007 Aug;16(8):1285-94. doi: 10.1517/13543784.16.8.1285.
引用本文的文献
1
Authors' Response to Silverman and Colleagues' Comment on "Review of Case Narratives from Fatal Overdoses Associated with Injectable Naltrexone for Opioid Dependence".作者对西尔弗曼及其同事就《与用于阿片类药物依赖的注射用纳曲酮相关的致命过量用药病例叙述回顾》所做评论的回应。
Drug Saf. 2018 Oct;41(10):995-997. doi: 10.1007/s40264-018-0692-9.
本文引用的文献
1
Naltrexone Maintenance: Effect on Morphine Sensitivity in Normal Volunteers.纳曲酮维持治疗：对正常志愿者吗啡敏感性的影响。
Am J Addict. 1993;2(1):34-38.
2
Review of Case Narratives from Fatal Overdoses Associated with Injectable Naltrexone for Opioid Dependence.注射用纳曲酮治疗阿片类药物依赖致致命过量病例报告综述。
Drug Saf. 2018 Oct;41(10):981-988. doi: 10.1007/s40264-018-0653-3.
3
Extended-release naltrexone (XR-NTX) for opioid use disorder in clinical practice: Vivitrol's Cost and Treatment Outcomes Registry.临床实践中用于治疗阿片类药物使用障碍的纳曲酮长效制剂（XR-NTX）：Vivitrol 的成本和治疗结果登记。
Addiction. 2018 Aug;113(8):1477-1487. doi: 10.1111/add.14199. Epub 2018 Apr 1.
4
Extended-release naltrexone: good but not a panacea.长效纳曲酮：效果良好但并非万灵药。
Lancet. 2018 Jan 27;391(10118):283-284. doi: 10.1016/S0140-6736(17)32872-6. Epub 2017 Nov 14.
5
Medications for opioid use disorder: bridging the gap in care.用于阿片类物质使用障碍的药物：弥合治疗差距。
Lancet. 2018 Jan 27;391(10118):285-287. doi: 10.1016/S0140-6736(17)32893-3. Epub 2017 Nov 14.
6
Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X:BOT): a multicentre, open-label, randomised controlled trial.长效纳曲酮与丁丙诺啡-纳洛酮预防阿片类药物复发的比较效果（X:BOT）：一项多中心、开放标签、随机对照试验。
Lancet. 2018 Jan 27;391(10118):309-318. doi: 10.1016/S0140-6736(17)32812-X. Epub 2017 Nov 14.
7
Effectiveness of Injectable Extended-Release Naltrexone vs Daily Buprenorphine-Naloxone for Opioid Dependence: A Randomized Clinical Noninferiority Trial.注射用长效纳曲酮与每日服用丁丙诺啡-纳洛酮治疗阿片类药物依赖的疗效比较：一项随机临床非劣效性试验。
JAMA Psychiatry. 2017 Dec 1;74(12):1197-1205. doi: 10.1001/jamapsychiatry.2017.3206.
8
Injectable naltrexone, oral naltrexone, and buprenorphine utilization and discontinuation among individuals treated for opioid use disorder in a United States commercially insured population.在美国商业保险人群中，接受阿片类药物使用障碍治疗的个体中，可注射纳曲酮、口服纳曲酮和丁丙诺啡的使用和停药情况。
J Subst Abuse Treat. 2018 Feb;85:90-96. doi: 10.1016/j.jsat.2017.07.001. Epub 2017 Jul 3.
9
Fatal and non-fatal opioid overdose in opioid dependent patients treated with methadone, buprenorphine or implant naltrexone.接受美沙酮、丁丙诺啡或植入式纳曲酮治疗的阿片类药物依赖患者的致命和非致命阿片类药物过量情况。
Int J Drug Policy. 2017 Aug;46:54-60. doi: 10.1016/j.drugpo.2017.05.039. Epub 2017 Jun 10.
10
Open-label Study of Injectable Extended-release Naltrexone (XR-NTX) in Healthcare Professionals With Opioid Dependence.注射用缓释纳曲酮（XR-NTX）用于治疗阿片类药物依赖的医疗专业人员的开放标签研究。
J Addict Med. 2017 May/Jun;11(3):224-230. doi: 10.1097/ADM.0000000000000302.
Zotero 插件